KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 146 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,507,500 | +4.0% | 1,125,000 | +38.9% | 0.86% | +6.2% |
Q2 2023 | $1,449,900 | +55.3% | 810,000 | +237.5% | 0.80% | +25.0% |
Q1 2023 | $933,600 | +3.7% | 240,000 | +71.4% | 0.64% | +145.8% |
Q4 2021 | $900,000 | +13.6% | 140,000 | +2.9% | 0.26% | +30.3% |
Q3 2021 | $792,000 | -5.8% | 136,000 | +66.9% | 0.20% | -11.8% |
Q2 2021 | $841,000 | +53.7% | 81,500 | +56.7% | 0.23% | +23.9% |
Q1 2021 | $547,000 | +108.0% | 52,000 | +205.9% | 0.18% | +67.3% |
Q4 2020 | $263,000 | – | 17,000 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |